RealView Imaging is a company.
RealView Imaging has raised $10.0M across 1 funding round.
Key people at RealView Imaging.
RealView Imaging has raised $10.0M in total across 1 funding round.
Key people at RealView Imaging.
RealView Imaging has raised $10.0M in total across 1 funding round.
RealView Imaging's investors include Accel, Alon MedTech Ventures, Cyberstarts VC, Glilot Capital Partners, Insight Partners, Scale Asia Ventures, Tamar Technology Ventures, Team8, Benny Schnaider, Efi Cohen.
RealView Imaging is an Israeli startup pioneering interactive live 3D holography for medical imaging, revolutionizing procedures like heart surgery and training with its HOLOSCOPE™-i system.[1][2][3] The company serves surgeons and physicians by enabling them to "touch" and manipulate accurate, interactive holograms derived from ultrasound or CT data, solving the limitations of 2D screens that restrict precision during operations.[1][2] This addresses unmet needs in the growing medical holography market, with systems deployed in leading hospitals like Schneider Children’s Medical Centre and backed by a $10 million Series C round.[1]
Founded in 2008 in Yokneam, Israel, RealView Imaging emerged to tackle the constraints of traditional 2D medical imaging, creating the world's first interactive live holography platform.[1][2] Key figure Aviad Kaufman has championed the vision, describing it as providing surgeons with "X-ray eyes" for true 3D visualization.[1] Early milestones include field deployments, a 2020 installation at Israel's largest pediatric hospital, and a Series C funding round that expanded the board with global experts, fueling commercialization efforts.[1]
RealView Imaging rides the wave of medical holography and AR/VR in healthcare, a rapidly expanding field driven by demands for minimally invasive, high-precision surgery amid aging populations and tech advancements in imaging.[1] Timing aligns with post-2020 adoption in top centers, amplified by funding and partnerships with oncology leaders, positioning it to influence surgical standards globally.[1] By freeing data from 2D confines, it accelerates training, reduces errors, and shapes ecosystem shifts toward holographic tools in prestigious hospitals and medtech firms.[1][2]
RealView is poised for commercialization breakthroughs, with body-projected holograms enabling gentler, tumor-precise surgeries and broader adoption in oncology and pediatrics.[1] Trends like AI-enhanced imaging and regulatory nods for AR medtech will propel growth, potentially expanding influence through global installations and medtech alliances. As the pioneer in live holography, it stands to redefine surgical accuracy, turning opaque procedures into transparent triumphs.[1][2]
RealView Imaging has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series C in July 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2020 | $10.0M Series C | Accel, Alon MedTech Ventures, Cyberstarts VC, Glilot Capital Partners, Insight Partners, Scale Asia Ventures, Tamar Technology Ventures, Team8, Benny Schnaider, Efi Cohen |
